ISRG Intuitive Surgical NASDAQ pre-market 23 Feb 2026: ISRG stock +20.56% upside
ISRG stock opened pre-market at USD 499.53 on 23 Feb 2026 as investors weigh strong quarterly growth and mixed valuation signals. Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of USD 2.87 billion and EPS beat in January, keeping surgical-robot momentum intact. The company trades at PE 63.88 and a market cap near USD 179,003,395,960.00, so the growth story must outpace valuation to drive gains. Meyka AI provides model-driven signals to frame the risk/reward for AI-focused portfolios.
ISRG stock snapshot and recent price action
ISRG stock last quoted USD 499.53 with a day low of USD 495.25 and day high of USD 503.73. The one-year range is USD 425.00 to USD 609.08, and average daily volume is 1,919,676.00 shares.
Trading trends show a 50-day moving average of USD 542.29 and a 200-day average of USD 515.97, indicating near-term pressure versus the medium-term trend. Institutional ownership sits at 83.64%, which supports liquidity but can amplify directional moves.
ISRG earnings and news driving the outlook
Intuitive Surgical reported EPS 2.53 for the January quarter and revenue USD 2.87 billion, beating consensus and showing revenue growth of 18.80% year-over-year. Analysts raised and trimmed targets after that print, leaving a consensus price target of USD 617.23.
Recent filings show continued institutional buying and insider sales. For transaction details and filings, see the MarketBeat coverage and historical price context on Investing.com: MarketBeat report on recent filings and Investing.com ISRG price history.
ISRG valuation and financials
Valuation is rich: ISRG trades at PE 63.88, price-to-sales 17.78, and price-to-book 10.04. Revenue per share is 28.36 and net income per share is 8.05, highlighting strong margins but high multiple exposure.
Balance-sheet strength is a clear positive. Cash per share is 16.72, debt-to-equity is 0.02, and current ratio is 4.87, which supports capital allocation for R&D and install growth while keeping leverage minimal.
ISRG technicals and trading signals
Technical indicators show mixed momentum. RSI is 46.30, MACD histogram is 3.64, and ATR is 13.02, pointing to moderate volatility. Bollinger Bands middle sits at USD 498.82, with an upper band at USD 530.43.
Short-term buyers watch the 50-day average at USD 542.29, while longer-term support clusters near the 200-day average at USD 515.97. On-balance volume and money-flow suggest neutral institutional flows.
Meyka Grade & Forecast for ISRG stock
Meyka AI rates ISRG with a score out of 100: 79.70 — Grade B+, Suggestion: BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a 12-month target of USD 602.22. Versus the current price USD 499.53, that implies an upside of 20.56%. Forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.
Final Thoughts
Intuitive Surgical (ISRG) remains a core growth name in healthcare robotics, with a mixed but constructive data set for AI-focused stock selection. The company delivered a strong January quarter with USD 2.87 billion revenue and rising EPS. Valuation is high at PE 63.88, which raises sensitivity to execution and surgical procedure trends. Our model projects a one-year level near USD 602.22, implying +20.56% from USD 499.53 today, while consensus analyst targets average USD 617.23. Technicals show short-term pressure under the 50-day average but healthy medium-term support. Investors using AI stocks as a strategy should weigh Intuitive’s market leadership, recurring instrument revenue, and cash-rich balance sheet against rich multiples and recent insider sales. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts are model outputs and do not guarantee future returns.
FAQs
What is the current price and valuation for ISRG stock?
ISRG stock trades at USD 499.53 with a PE of 63.88, price-to-sales 17.78, and market cap near USD 179,003,395,960.00. Valuation is premium versus peers.
What does Meyka AI forecast say about ISRG stock?
Meyka AI’s forecast model projects USD 602.22 for ISRG stock in 12 months, implying +20.56% upside from USD 499.53. Forecasts are model-based and not guarantees.
How did ISRG earnings affect the ISRG stock outlook?
ISRG earnings beat with EPS 2.53 and revenue USD 2.87 billion, supporting the growth narrative. The print lifted analyst targets but left valuation debates open.
What are the main risks for ISRG stock investors?
Key ISRG stock risks include stretched valuation, procedure volume variability, regulatory or reimbursement shifts, and concentrated competitive dynamics in robotic surgery.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.